Century Therapeutics (IPSC) EPS (Basic) (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly EPS (Basic) of -$0.47 for Q1 2026, down 152.8% year-over-year from $0.89 in Q1 2025, and down 326.02% quarter-over-quarter from -$0.11 in Q4 2025.
Century Therapeutics (IPSC) EPS (Basic) (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported EPS (Basic) for 7 consecutive years, with -$0.47 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 152.8% year-over-year to -$0.47; the TTM figure through Mar 2026 stood at -$0.87 (down 245.48% YoY), while the FY2025 annual figure was $0.02, up 101.49% from the prior year.
- EPS (Basic) fell to -$0.47 in Q1 2026 per IPSC's latest filing, from -$0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.89 in Q1 2025 and bottomed at -$0.66 in Q4 2023.
- Historically, EPS (Basic) has averaged -$0.39 across 5 years, with a median of -$0.47 in 2026.
- Annual changes were most pronounced in 2025 — EPS (Basic) surged 297.58% — and 2026, when it slumped 152.8%.
- Century Therapeutics' EPS (Basic) stood at -$0.55 in 2022, then slipped by 21.09% to -$0.66 in 2023, then surged by 31.71% to -$0.45 in 2024, then jumped by 75.68% to -$0.11 in 2025, then slumped by 326.02% to -$0.47 in 2026.
- Business Quant data shows IPSC's EPS (Basic) at -$0.47 in Q1 2026, -$0.11 in Q4 2025, and -$0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | -0.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.47 |
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | 0.89 |
| Dec 31, 2024 | -0.45 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.38 |
| Mar 31, 2024 | -0.45 |
| Dec 31, 2023 | -0.66 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.56 |
| Mar 31, 2023 | -0.53 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.54 |
| Mar 31, 2022 | -0.66 |
| Dec 31, 2021 | -0.87 |
| Sep 30, 2021 | -0.48 |